Thioridazine was approved by the U.S. FDA in 1959.

However, the manufacturer (Novartis/Sandoz/Wander) of the brands of thioridazine - Mellaril® in the US and Canada and Melleril® in Europe - discontinued the drug worldwide in June 2005.

Nevertheless, thioridazine may still be available from other manufacturers as a generic drug with the precaution that it is used only in psychotic patients refractory to other forms of drug treatment.

Please visit the official site of the FDA for further information.

 

Why is this medication prescribed?

Other uses for this medicine

Dosage and using this medicine

What special precautions should I follow?

What should I do if I forget a dose?

What side effects can this medication cause?

What storage conditions are needed for this medicine?

In case of an emergency/overdose